MK 212 hydrochloride5-HT2C agonist CAS# 61655-58-1 |
- Nelfinavir Mesylate
Catalog No.:BCC1794
CAS No.:159989-65-8
- Fluorouracil (Adrucil)
Catalog No.:BCC2135
CAS No.:51-21-8
- HIV-1 integrase inhibitor
Catalog No.:BCC1618
CAS No.:544467-07-4
- Elvitegravir (GS-9137)
Catalog No.:BCC2134
CAS No.:697761-98-1
- BMS-707035
Catalog No.:BCC2133
CAS No.:729607-74-3
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 61655-58-1 | SDF | Download SDF |
| PubChem ID | 198421 | Appearance | Powder |
| Formula | C8H12Cl2N4 | M.Wt | 235.12 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 50 mM in water with gentle warming | ||
| Chemical Name | 2-chloro-6-piperazin-1-ylpyrazine;hydrochloride | ||
| SMILES | C1CN(CCN1)C2=CN=CC(=N2)Cl.Cl | ||
| Standard InChIKey | PFIZGLUIYAZQFU-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C8H11ClN4.ClH/c9-7-5-11-6-8(12-7)13-3-1-10-2-4-13;/h5-6,10H,1-4H2;1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 5-HT receptor agonist; displays selectivity for 5-HT2C over 5-HT2A (IC50 values are 0.028 and 0.42 μM for human 5-HT2C and 5-HT2A receptors expressed in HEK293 cells respectively). |
MK 212 hydrochloride Dilution Calculator
MK 212 hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.2531 mL | 21.2657 mL | 42.5315 mL | 85.0629 mL | 106.3287 mL |
| 5 mM | 0.8506 mL | 4.2531 mL | 8.5063 mL | 17.0126 mL | 21.2657 mL |
| 10 mM | 0.4253 mL | 2.1266 mL | 4.2531 mL | 8.5063 mL | 10.6329 mL |
| 50 mM | 0.0851 mL | 0.4253 mL | 0.8506 mL | 1.7013 mL | 2.1266 mL |
| 100 mM | 0.0425 mL | 0.2127 mL | 0.4253 mL | 0.8506 mL | 1.0633 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Propargyl p-toluenesulfonate
Catalog No.:BCN2266
CAS No.:6165-76-0
- Propargyl benzenesulfonate
Catalog No.:BCN2247
CAS No.:6165-75-9
- Protopine hydrochloride
Catalog No.:BCN5345
CAS No.:6164-47-2
- Amfenac Sodium Monohydrate
Catalog No.:BCC4620
CAS No.:61618-27-7
- Songoroside A
Catalog No.:BCN3988
CAS No.:61617-29-6
- (-)-Sparteine Sulfate Pentahydrate
Catalog No.:BCC8273
CAS No.:6160-12-9
- Acetylcysteine
Catalog No.:BCC3716
CAS No.:616-91-1
- H-DL-Nle-OH
Catalog No.:BCC3301
CAS No.:616-06-8
- 13-Hydroxy-8,11,13-podocarpatrien-18-oic acid
Catalog No.:BCN1399
CAS No.:61597-83-9
- 15,16-Epoxy-12R-hydroxylabda-8(17),13(16),14-triene
Catalog No.:BCN1400
CAS No.:61597-55-5
- Vasicine
Catalog No.:BCN4140
CAS No.:6159-55-3
- DHBP dibromide
Catalog No.:BCC6811
CAS No.:6159-05-3
- Furomollugin
Catalog No.:BCN4141
CAS No.:61658-41-1
- 11-Methoxyuncarine C
Catalog No.:BCN4142
CAS No.:61665-08-5
- Neridienone B
Catalog No.:BCN4143
CAS No.:61671-56-5
- Trimethyl[3-(methylthio)propyl]ammonium(1+)
Catalog No.:BCN1398
CAS No.:61672-50-2
- 3-(Dimethylsulfonio)-N,N,N-trimethylpropanaminium(2+)
Catalog No.:BCN1397
CAS No.:61672-51-3
- H-Alaninol
Catalog No.:BCC2731
CAS No.:6168-72-5
- OMDM-2
Catalog No.:BCC5814
CAS No.:616884-63-0
- Ethyl vanillate
Catalog No.:BCN3670
CAS No.:617-05-0
- 2-Hydroxy-1-methoxyanthraquinone
Catalog No.:BCN3091
CAS No.:6170-06-5
- 2-Chloro-1,4-phenylenediamine sulfate
Catalog No.:BCN8435
CAS No.:61702-44-1
- W-5 hydrochloride
Catalog No.:BCC6621
CAS No.:61714-25-8
- W-7 hydrochloride
Catalog No.:BCC6622
CAS No.:61714-27-0
Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties.[Pubmed:23301527]
J Med Chem. 2013 Feb 14;56(3):1211-27.
The isoxazol-3-one tautomer of the bicyclic isoxazole, 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol (THAZ), has previously been shown to be a weak GABA(A) and glycine receptor antagonist. In the present study, the potential in this scaffold has been explored through the synthesis and pharmacological characterization of a series of N- and O-substituted THAZ analogues. The analogues N-Bn-THAZ (3d) and O-Bn-THAZ (4d) were found to be potent agonists of the human 5-HT(2A) and 5-HT(2C) receptors. Judging from an elaborate pharmacological profiling at numerous other CNS targets, the 3d analogue appears to be selective for the two receptors. Administration of 3d substantially improved the cognitive performance of mice in a place recognition Y-maze model, an effect fully reversible by coadministration of the selective 5-HT(2C) antagonist SB242084. In conclusion, as novel bioavailable cognitive enhancers that most likely mediate their effects through 5-HT(2A) and/or 5-HT(2C) receptors, the isoxazoles 3d and 4d constitute interesting leads for further medicinal chemistry development.
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.[Pubmed:8891601]
Eur J Pharmacol. 1996 Sep 12;311(2-3):207-11.
The possible involvement of 5-HT2A or 5-HT2C receptors in the elevation of serum corticosterone in rats by quipazine (2-(1-piperazinyl)quinoline maleate) and MK-212 (6-chloro-(1-piperazinyl)pyrazine), direct-acting 5-HT receptor agonists, was investigated by the use of two newly available receptor antagonists, SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea) and MDL 100,907 (R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]- 4-piperidinemethanol). MDL 100,907 blocked the increase in serum corticosterone elicited by quipazine and MK-212 with ED50 values of 0.0028 and 0.0027 mg/kg, s.c., respectively. In contrast, SB 200646A only partially antagonized the serum corticosterone concentration increases by quipazine and MK-212 even at the highest dose tested, 40 mg/kg, i.p. Because published data show the affinities of MDL 100,907 and SB 200646A for 5-HT2C receptors to be nearly identical, whereas the affinity of MDL 100,907 for 5-HT2A receptors is 17500-fold higher than that of SB 200646A, our findings suggest that 5-HT2A receptors rather than 5-HT2C receptors mediate the serum corticosterone increases by both quipazine and MK-212.
Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.[Pubmed:3039120]
J Pharmacol Exp Ther. 1987 Aug;242(2):552-7.
Serotonin (5-HT)-stimulated phosphoinositide hydrolysis is mediated by the 5-HT-2 receptor in rat cerebral cortex and by the 5-HT-1c receptor in rat choroid plexus. These systems were used to determine relative efficacies of piperazine derivatives at the 5-HT-2 and 5-HT-1c receptors. Both quipazine and 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) stimulated phosphoinositide hydrolysis in cerebral cortex, and these effects were blocked by ketanserin. The maximum responses to these agonists were 80% of the maximum response to 5-HT. m-Trifluoromethylphenylpiperazine (TFMPP), m-chlorophenylpiperazine (MCPP) and 1-(1-naphthyl)-piperazine (1-NP) did not stimulate phosphoinositide hydrolysis in cerebral cortex at concentrations that blocked the effect of 5-HT. In the choroid plexus, TFMPP and MCPP, as well as MK-212 and quipazine, increased phosphoinositide hydrolysis and mianserin blocked these effects. MK-212 had an efficacy which was equal to that of 5-HT, whereas quipazine, MCPP and TFMPP were partial agonists in the choroid plexus. 1-NP did not stimulate phosphoinositide hydrolysis in choroid plexus but completely blocked the effect 5-HT. On the basis of these data, we conclude that quipazine and MK-212 are partial agonists at 5-HT-2 receptors in cerebral cortex, whereas 1-NP, TFMPP and MCPP are pure antagonists of the cortical 5-HT-2 receptor. However, TFMPP and MCPP as well as quipazine and MK-212 are agonists at the 5-HT-1c receptor, while 1-NP is a pure antagonist of the 5-HT-1c receptor in choroid plexus.
